These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20094041)

  • 1. JNK deficiency enhances fatty acid utilization and diverts glucose from oxidation to glycogen storage in cultured myotubes.
    Vijayvargia R; Mann K; Weiss HR; Pownall HJ; Ruan H
    Obesity (Silver Spring); 2010 Sep; 18(9):1701-9. PubMed ID: 20094041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
    Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM
    Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
    Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
    J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
    Al-Khalili L; Bouzakri K; Glund S; Lönnqvist F; Koistinen HA; Krook A
    Mol Endocrinol; 2006 Dec; 20(12):3364-75. PubMed ID: 16945991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of Nck1 attenuates hepatic ER stress signaling and improves glucose tolerance and insulin signaling in liver of obese mice.
    Latreille M; Laberge MK; Bourret G; Yamani L; Larose L
    Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E423-34. PubMed ID: 20587749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels.
    Pedrini MT; Kranebitter M; Niederwanger A; Kaser S; Engl J; Debbage P; Huber LA; Patsch JR
    Diabetologia; 2005 Apr; 48(4):756-66. PubMed ID: 15747109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased insulin action in skeletal muscle from patients with McArdle's disease.
    Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing Jnk1 and Jnk2 accelerates basal lipolysis and promotes fatty acid re-esterification in mouse adipocytes.
    Rozo AV; Vijayvargia R; Weiss HR; Ruan H
    Diabetologia; 2008 Aug; 51(8):1493-504. PubMed ID: 18528680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin improves insulin resistance in skeletal muscle of rats.
    Na LX; Zhang YL; Li Y; Liu LY; Li R; Kong T; Sun CH
    Nutr Metab Cardiovasc Dis; 2011 Jul; 21(7):526-33. PubMed ID: 20227862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle.
    Bouzakri K; Austin R; Rune A; Lassman ME; Garcia-Roves PM; Berger JP; Krook A; Chibalin AV; Zhang BB; Zierath JR
    Diabetes; 2008 Jun; 57(6):1508-16. PubMed ID: 18314420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
    Kim E; Lee JH; Ntambi JM; Hyun CK
    Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells.
    Zhou QG; Hou FF; Guo ZJ; Liang M; Wang GB; Zhang X
    Diabetes Metab Res Rev; 2008 Sep; 24(6):459-64. PubMed ID: 18551686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
    Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
    Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACC2 Deletion Enhances IMCL Reduction Along With Acetyl-CoA Metabolism and Improves Insulin Sensitivity in Male Mice.
    Takagi H; Ikehara T; Kashiwagi Y; Hashimoto K; Nanchi I; Shimazaki A; Nambu H; Yukioka H
    Endocrinology; 2018 Aug; 159(8):3007-3019. PubMed ID: 29931154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
    Gancz D; Donin N; Fishelson Z
    Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y; Li Y; Wang Y; Wen Y; Sun C
    Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inositol-requiring enzyme 1α and c-Jun N-terminal kinase axis activation contributes to intracellular lipid accumulation in calf hepatocytes.
    Gao W; Wang Y; Liu S; Li G; Shao Q; Zhang C; Cao L; Liu K; Gao W; Yang Z; Dong Y; Du X; Lei L; Liu G; Li X
    J Dairy Sci; 2024 May; 107(5):3127-3139. PubMed ID: 37939835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
    Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation.
    Sipula IJ; Brown NF; Perdomo G
    Metabolism; 2006 Dec; 55(12):1637-44. PubMed ID: 17142137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.